Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Adequate humorale respons op SARS-CoV-2-infectie na levertransplantatie
jan 2022 | Hepatologie, Virale infecties